首页 > 最新文献

Menopause international最新文献

英文 中文
Fifteen medical societies agree on hormone therapy statement. 15个医学协会同意激素治疗声明。
Pub Date : 2012-12-01
Simon Brown
{"title":"Fifteen medical societies agree on hormone therapy statement.","authors":"Simon Brown","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":87478,"journal":{"name":"Menopause international","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2012-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"31202476","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Advanced nursing practice in menopause nursing. 绝经期护理的高级护理实践。
Pub Date : 2012-12-01 Epub Date: 2012-10-26 DOI: 10.1258/mi.2012.012035
Debby Holloway

Advanced nursing practice is a complex term that has been explored over the last 10 years within nursing as nurses have changed the boundaries of their clinical care to try and meet the needs of their patients in a rapidly changing health-care setting. These roles are attractive to nurses as they can remain primarily clinically based as they progress within their careers. However there is currently no standardization in relation to job titles, educational provisions or regulations. The Department of Health issued guidance in 2010, but there is nothing mandatory to date. This short article will look at the issues involved in advanced practice in menopause nursing.

高级护理实践是一个复杂的术语,在过去的10年里,护士已经改变了他们的临床护理的界限,试图满足病人在快速变化的医疗保健环境中的需求。这些角色对护士很有吸引力,因为他们可以在职业发展中主要以临床为基础。然而,目前在职称、教育规定或条例方面没有标准化。卫生部在2010年发布了指导意见,但到目前为止还没有强制性的规定。这篇短文将着眼于更年期护理高级实践中涉及的问题。
{"title":"Advanced nursing practice in menopause nursing.","authors":"Debby Holloway","doi":"10.1258/mi.2012.012035","DOIUrl":"https://doi.org/10.1258/mi.2012.012035","url":null,"abstract":"<p><p>Advanced nursing practice is a complex term that has been explored over the last 10 years within nursing as nurses have changed the boundaries of their clinical care to try and meet the needs of their patients in a rapidly changing health-care setting. These roles are attractive to nurses as they can remain primarily clinically based as they progress within their careers. However there is currently no standardization in relation to job titles, educational provisions or regulations. The Department of Health issued guidance in 2010, but there is nothing mandatory to date. This short article will look at the issues involved in advanced practice in menopause nursing.</p>","PeriodicalId":87478,"journal":{"name":"Menopause international","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2012-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1258/mi.2012.012035","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"31009913","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Early menopause linked to increased risk of cerebral aneurysm. 过早绝经会增加患脑动脉瘤的风险。
Pub Date : 2012-09-01 DOI: 10.1258/mi.2012.012029
Simon Brown
The appearance of occasional masculine features seen in some women after the menopause may be the result of a genetic malfunction complicated by the loss of endogenous estrogen. However, the implications of this suggestion – made in a study reported in the journal Cell in December – stretch before and beyond the menopause and into the whole lifespan of sex determination and gender maintenance. The study found, contrary to what are most people’s expectations, that gender does not depend solely on the arrangement of chromosomes. Its collaborating investigators from the European Molecular Biology Laboratory (EMBL) in Heidelberg, Germany, and the Medical Research Council’s National Institute for Medical Research (NIMR) in London, found that, if a certain gene located on a non-sex chromosome is turned off, cells in the ovaries of adult female mice turn into cells typically found in testes. The study thus challenges the long-held assumption that the development of female traits is the default pathway of nature – that is, an embryo’s default route to gender determination would be female unless a transcription factor gene known as SRY was located on the Y chromosome. The gene which appears to be instrumental in this process is known as FOXL2, and this study showed – in the mouse model – that deletion of FOXL2 in adult ovarian follicles leads to the immediate upregulation of testis-specific genes, including the critical SRY gene. Significantly, FOXL2 is located not on the sex chromosomes but on an autosome, and is therefore present in both sexes. When the FOXL2 gene was ablated (switched off) in the mouse ovaries, the investigators were surprised by the results. ‘We expected the mice to stop producing oocytes, but what happened was much more dramatic,’ said EMBL investigator Mathias Trier. ‘Somatic cells which support the developing egg took on the characteristics of the cells which usually support developing sperm, and the gender-specific hormone-producing cells also switched from a female to a male cell type’. However, it was when the EMBL scientists teamed up with the NIMR group of Robin Lovell-Badge in London that an explanation for this battle of the sexes emerged and how FOXL2 plays such a crucial role in keeping female mice female. They showed that FOXL2 and the estrogen receptors actually interact to regulate expression of the testes-promoting gene known as Sox9. Sox9 has for a while been known to function in the embryo to make the early gonads become testes rather than ovaries, but this new study now suggests that Sox9 performs its same duties in the adult as well. Thus, FOXL2 – in its interaction with estrogen – is critical to keep Sox9 turned off in ovaries throughout life, and therefore to prevent any male effects and keep females feminine. Maintenance of the ovarian phenotype is thus an active process throughout life; FOXL2 and Sox9 oppose each other’s action to ensure not just the formation but also the maintenance of the different female an
{"title":"Early menopause linked to increased risk of cerebral aneurysm.","authors":"Simon Brown","doi":"10.1258/mi.2012.012029","DOIUrl":"https://doi.org/10.1258/mi.2012.012029","url":null,"abstract":"The appearance of occasional masculine features seen in some women after the menopause may be the result of a genetic malfunction complicated by the loss of endogenous estrogen. However, the implications of this suggestion – made in a study reported in the journal Cell in December – stretch before and beyond the menopause and into the whole lifespan of sex determination and gender maintenance. The study found, contrary to what are most people’s expectations, that gender does not depend solely on the arrangement of chromosomes. Its collaborating investigators from the European Molecular Biology Laboratory (EMBL) in Heidelberg, Germany, and the Medical Research Council’s National Institute for Medical Research (NIMR) in London, found that, if a certain gene located on a non-sex chromosome is turned off, cells in the ovaries of adult female mice turn into cells typically found in testes. The study thus challenges the long-held assumption that the development of female traits is the default pathway of nature – that is, an embryo’s default route to gender determination would be female unless a transcription factor gene known as SRY was located on the Y chromosome. The gene which appears to be instrumental in this process is known as FOXL2, and this study showed – in the mouse model – that deletion of FOXL2 in adult ovarian follicles leads to the immediate upregulation of testis-specific genes, including the critical SRY gene. Significantly, FOXL2 is located not on the sex chromosomes but on an autosome, and is therefore present in both sexes. When the FOXL2 gene was ablated (switched off) in the mouse ovaries, the investigators were surprised by the results. ‘We expected the mice to stop producing oocytes, but what happened was much more dramatic,’ said EMBL investigator Mathias Trier. ‘Somatic cells which support the developing egg took on the characteristics of the cells which usually support developing sperm, and the gender-specific hormone-producing cells also switched from a female to a male cell type’. However, it was when the EMBL scientists teamed up with the NIMR group of Robin Lovell-Badge in London that an explanation for this battle of the sexes emerged and how FOXL2 plays such a crucial role in keeping female mice female. They showed that FOXL2 and the estrogen receptors actually interact to regulate expression of the testes-promoting gene known as Sox9. Sox9 has for a while been known to function in the embryo to make the early gonads become testes rather than ovaries, but this new study now suggests that Sox9 performs its same duties in the adult as well. Thus, FOXL2 – in its interaction with estrogen – is critical to keep Sox9 turned off in ovaries throughout life, and therefore to prevent any male effects and keep females feminine. Maintenance of the ovarian phenotype is thus an active process throughout life; FOXL2 and Sox9 oppose each other’s action to ensure not just the formation but also the maintenance of the different female an","PeriodicalId":87478,"journal":{"name":"Menopause international","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2012-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1258/mi.2012.012029","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30982664","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Web-based survey 'Contraception and attitudes to sexual behaviour' completed by women accessing a UK menopause website. 一项名为“避孕和对性行为的态度”的网络调查由英国更年期网站的女性完成。
Pub Date : 2012-09-01 Epub Date: 2012-07-03 DOI: 10.1258/mi.2012.012020
Grant P Cumming, Rosemary Cochrane, Heather D Currie, Rik Moncur, Amanda J Lee

Background and methodology: Sociodemographic trends mean increasing numbers of new relationships in later life. These trends may not only have health consequences for women and health services but also impact on the targeting of sexual health messages. This study aimed to examine attitudes and knowledge surrounding contraception, sexual health and unwanted pregnancy among those accessing the website www.menopausematters.co.uk. A voluntary online survey was completed.

Results: Survey was completed by 550 respondents. Three hundred and sixty-six women, 94% of whom self-classified as pre- or perimenopausal, had been sexually active with a male partner in the previous four weeks. Commonest contraceptive methods used by perimenopausal and postmenopausal women were condoms, combined oral contraceptive pill (COCP) and male sterilization. Up to 42% of women surveyed were unhappy with their contraception. A total of 27% premenopausal, 32% perimenopausal women and 40% postmenopausal used no contraception. One-third of women were unhappy about this and 19 unplanned pregnancies had occurred. The majority of women were informed regarding COCP use over 35 years, hormone replacement therapy, emergency contraception and ceasing contraception. The majority of women were unaware that more terminations of pregnancy are performed in women over 40 than any other age group per total pregnancies.Almost a third of women were unaware that chlamydia incidence is increasing in older women. Most would use condoms in new relationship.

Discussion and conclusions: Women accessing www.menopausematters.co.uk are well informed about contraception and sexual health. The majority of those accessing the site are sexually active, but many use no contraception, or are unhappy with their chosen method, leaving them vulnerable to unwanted pregnancy or sexually transmitted infection.

背景和方法:社会人口趋势意味着在晚年生活中新关系的数量增加。这些趋势不仅可能对妇女和保健服务产生健康后果,而且还可能影响性健康信息的针对性。这项研究旨在调查访问www.menopausematters.co.uk网站的人对避孕、性健康和意外怀孕的态度和知识。一项自愿在线调查已经完成。结果:共有550名受访者完成调查。366名女性,其中94%自我归类为绝经前或围绝经期,在过去四周内与男性伴侣发生过性行为。围绝经期和绝经后妇女最常用的避孕方法是避孕套、复方口服避孕药(COCP)和男性绝育。多达42%的受访女性对自己的避孕方法不满意。共有27%的绝经前妇女、32%的围绝经期妇女和40%的绝经后妇女没有采取避孕措施。三分之一的女性对此感到不满,有19人意外怀孕。大多数妇女被告知使用COCP超过35年、激素替代疗法、紧急避孕和停止避孕。大多数妇女不知道,40岁以上妇女的终止妊娠率高于其他任何年龄组。几乎三分之一的妇女不知道衣原体在老年妇女中的发病率正在增加。大多数人会在新恋情中使用避孕套。讨论和结论:访问www.menopausematters.co.uk的妇女对避孕和性健康有很好的了解。大多数访问该网站的人都是性活跃的,但许多人没有采取避孕措施,或者对他们选择的方法不满意,这使得他们很容易意外怀孕或性传播感染。
{"title":"Web-based survey 'Contraception and attitudes to sexual behaviour' completed by women accessing a UK menopause website.","authors":"Grant P Cumming,&nbsp;Rosemary Cochrane,&nbsp;Heather D Currie,&nbsp;Rik Moncur,&nbsp;Amanda J Lee","doi":"10.1258/mi.2012.012020","DOIUrl":"https://doi.org/10.1258/mi.2012.012020","url":null,"abstract":"<p><strong>Background and methodology: </strong>Sociodemographic trends mean increasing numbers of new relationships in later life. These trends may not only have health consequences for women and health services but also impact on the targeting of sexual health messages. This study aimed to examine attitudes and knowledge surrounding contraception, sexual health and unwanted pregnancy among those accessing the website www.menopausematters.co.uk. A voluntary online survey was completed.</p><p><strong>Results: </strong>Survey was completed by 550 respondents. Three hundred and sixty-six women, 94% of whom self-classified as pre- or perimenopausal, had been sexually active with a male partner in the previous four weeks. Commonest contraceptive methods used by perimenopausal and postmenopausal women were condoms, combined oral contraceptive pill (COCP) and male sterilization. Up to 42% of women surveyed were unhappy with their contraception. A total of 27% premenopausal, 32% perimenopausal women and 40% postmenopausal used no contraception. One-third of women were unhappy about this and 19 unplanned pregnancies had occurred. The majority of women were informed regarding COCP use over 35 years, hormone replacement therapy, emergency contraception and ceasing contraception. The majority of women were unaware that more terminations of pregnancy are performed in women over 40 than any other age group per total pregnancies.Almost a third of women were unaware that chlamydia incidence is increasing in older women. Most would use condoms in new relationship.</p><p><strong>Discussion and conclusions: </strong>Women accessing www.menopausematters.co.uk are well informed about contraception and sexual health. The majority of those accessing the site are sexually active, but many use no contraception, or are unhappy with their chosen method, leaving them vulnerable to unwanted pregnancy or sexually transmitted infection.</p>","PeriodicalId":87478,"journal":{"name":"Menopause international","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2012-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1258/mi.2012.012020","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30738386","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 5
Practice observed. 练习观察。
Pub Date : 2012-09-01 Epub Date: 2012-07-20 DOI: 10.1258/mi.2012.012021
Sally Darnborough
A 74-year-old lady attended my general practice surgery complaining that her urine was ‘pink’ and she had noted some vaginal bleeding. She was otherwise well and had no urinary or systemic symptoms to report other than ‘quite a lot of bruising on my bottom’. I know the lady well, she attends my Primary Care Menopause clinic for regular review as she is someone who has benefited from long-term use of estrogen replacement therapy (ERT). Having had a hysterectomy and bilateral oophorectomy in the past for fibroids she has remained on ERT ever since. Several attempts had been made over the years to withdraw hormone therapy (HT) but proved unsuccessful. There were frequent documented discussions assessing her risk profile, each time she opted to remain on ERT accepting any associated increased risks. At 74 she is extremely fit and active and a passionate equestrian. She is slim, a lifelong non-smoker with no history of hypertension or cardiovascular disease. The only history of note is osteopaenia detected on previous Dual X-ray absorpitometry scan. She continues to participate in regular breast screening and is on the lowest dose of transdermal estrogen required to control her symptoms. On closer questioning I discovered that she had just completed an adventurous horse trek over rough terrain and had been in the saddle for three days. Clinical examination revealed extensive bruising in the saddle region and inner thighs. There was spontaneous bleeding from the vaginal vault and vaginal mucosa; the vaginal walls were literally oozing blood. The vaginal vault was otherwise normal with no lacerations visible. Other than her ‘pink’ urine (frank haematuria), vaginal bleeding and impressive bruising she had no complaints and felt perfectly well. I reviewed her notes looking for clues and discovered that since her last review at the menopause clinic she had undergone investigation of a ‘dizzy spell’ and had been referred to the Stroke Clinic to exclude a transient ischaemic attack. The history was unconvincing and all investigations were negative (electrocardiography, computed tomography scan, cardiac echo, carotid Doppler scans, chest X-ray, biochemistry and haematology were all normal). It was concluded she had probably experienced a vasovagal episode. Nevertheless, she was advised to stop her ERT and commence antiplatelet therapy (clopidogrel) and a statin for preventive purposes (as per SIGN 108.) She explained that since stopping her ERT she had been feeling awful and started self-medicating with Gingko biloba having heard it was a ‘natural’ remedy for menopausal symptoms. Alarm bells immediately rang – I had been lucky enough to attend the 2011 British Menopause Society conference, which included a lecture on ‘alternative therapies for the menopause’. The speaker described the commonly used alternative therapies and highlighted possible interactions and cautions. From the lecture I remembered hearing that Gingko biloba is known to interact with and po
{"title":"Practice observed.","authors":"Sally Darnborough","doi":"10.1258/mi.2012.012021","DOIUrl":"https://doi.org/10.1258/mi.2012.012021","url":null,"abstract":"A 74-year-old lady attended my general practice surgery complaining that her urine was ‘pink’ and she had noted some vaginal bleeding. She was otherwise well and had no urinary or systemic symptoms to report other than ‘quite a lot of bruising on my bottom’. I know the lady well, she attends my Primary Care Menopause clinic for regular review as she is someone who has benefited from long-term use of estrogen replacement therapy (ERT). Having had a hysterectomy and bilateral oophorectomy in the past for fibroids she has remained on ERT ever since. Several attempts had been made over the years to withdraw hormone therapy (HT) but proved unsuccessful. There were frequent documented discussions assessing her risk profile, each time she opted to remain on ERT accepting any associated increased risks. At 74 she is extremely fit and active and a passionate equestrian. She is slim, a lifelong non-smoker with no history of hypertension or cardiovascular disease. The only history of note is osteopaenia detected on previous Dual X-ray absorpitometry scan. She continues to participate in regular breast screening and is on the lowest dose of transdermal estrogen required to control her symptoms. On closer questioning I discovered that she had just completed an adventurous horse trek over rough terrain and had been in the saddle for three days. Clinical examination revealed extensive bruising in the saddle region and inner thighs. There was spontaneous bleeding from the vaginal vault and vaginal mucosa; the vaginal walls were literally oozing blood. The vaginal vault was otherwise normal with no lacerations visible. Other than her ‘pink’ urine (frank haematuria), vaginal bleeding and impressive bruising she had no complaints and felt perfectly well. I reviewed her notes looking for clues and discovered that since her last review at the menopause clinic she had undergone investigation of a ‘dizzy spell’ and had been referred to the Stroke Clinic to exclude a transient ischaemic attack. The history was unconvincing and all investigations were negative (electrocardiography, computed tomography scan, cardiac echo, carotid Doppler scans, chest X-ray, biochemistry and haematology were all normal). It was concluded she had probably experienced a vasovagal episode. Nevertheless, she was advised to stop her ERT and commence antiplatelet therapy (clopidogrel) and a statin for preventive purposes (as per SIGN 108.) She explained that since stopping her ERT she had been feeling awful and started self-medicating with Gingko biloba having heard it was a ‘natural’ remedy for menopausal symptoms. Alarm bells immediately rang – I had been lucky enough to attend the 2011 British Menopause Society conference, which included a lecture on ‘alternative therapies for the menopause’. The speaker described the commonly used alternative therapies and highlighted possible interactions and cautions. From the lecture I remembered hearing that Gingko biloba is known to interact with and po","PeriodicalId":87478,"journal":{"name":"Menopause international","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2012-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1258/mi.2012.012021","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30781179","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Menopause-specific quality of life of urban women in West Bengal, India. 印度西孟加拉邦城市妇女更年期特有的生活质量。
Pub Date : 2012-09-01 Epub Date: 2012-07-03 DOI: 10.1258/mi.2012.011107
Nivedita Som, Subha Ray

Objective: To find out the association of menopause-specific quality of life of women with both working status and duration of postmenopausal years.

Study design: We conducted a cross-sectional study on 250 postmenopausal women belonging to Bengali-speaking Hindu ethnic group, aged 47-62 years in the city of Kolkata, West Bengal, India. The participants were literate, living in wedlock with at least one surviving child, attained natural menopause at least two years ago and have never taken hormone replacement treatment. Menopause-specific quality of life was measured using a self-administered standard questionnaire (Menopause-Specific Quality of Life questionnaire, or MENQOL). MENQOL consisted of 29 menopausal symptoms (items) that are grouped under four domains. Additional information on sociodemographic aspect and reproductive history of the participants were collected using a pretested questionnaire. Main outcome measures Both bivariate and multivariate analyses showed that menopause-specific quality of life decreases with the increase in duration of postmenopausal years. Although bivariate analysis demonstrated that working women had a better menopause-specific quality of life than their non-working counterpart, multivariate linear regression model did not corroborate to this finding.

Conclusion: Duration of postmenopausal years had a significant association with menopause-specific quality of life of women.

目的:探讨妇女绝经期特异性生活质量与工作状态和绝经后持续时间的关系。研究设计:我们对印度西孟加拉邦加尔各答市的250名年龄在47-62岁的孟加拉语印度教绝经后妇女进行了横断面研究。这些参与者都受过教育,已婚,至少有一个幸存的孩子,至少在两年前达到自然更年期,从未接受过激素替代治疗。使用自我管理的标准问卷(绝经特异性生活质量问卷,或MENQOL)测量绝经特异性生活质量。MENQOL包括29个更年期症状(项目),分为四个领域。使用预测问卷收集了参与者的社会人口学方面和生殖史的其他信息。双变量和多变量分析均显示,绝经期特异性生活质量随绝经后持续时间的增加而下降。虽然双变量分析表明职业女性比非工作女性有更好的绝经期生活质量,但多元线性回归模型并没有证实这一发现。结论:绝经后的持续时间与绝经期妇女的生活质量有显著的相关性。
{"title":"Menopause-specific quality of life of urban women in West Bengal, India.","authors":"Nivedita Som,&nbsp;Subha Ray","doi":"10.1258/mi.2012.011107","DOIUrl":"https://doi.org/10.1258/mi.2012.011107","url":null,"abstract":"<p><strong>Objective: </strong>To find out the association of menopause-specific quality of life of women with both working status and duration of postmenopausal years.</p><p><strong>Study design: </strong>We conducted a cross-sectional study on 250 postmenopausal women belonging to Bengali-speaking Hindu ethnic group, aged 47-62 years in the city of Kolkata, West Bengal, India. The participants were literate, living in wedlock with at least one surviving child, attained natural menopause at least two years ago and have never taken hormone replacement treatment. Menopause-specific quality of life was measured using a self-administered standard questionnaire (Menopause-Specific Quality of Life questionnaire, or MENQOL). MENQOL consisted of 29 menopausal symptoms (items) that are grouped under four domains. Additional information on sociodemographic aspect and reproductive history of the participants were collected using a pretested questionnaire. Main outcome measures Both bivariate and multivariate analyses showed that menopause-specific quality of life decreases with the increase in duration of postmenopausal years. Although bivariate analysis demonstrated that working women had a better menopause-specific quality of life than their non-working counterpart, multivariate linear regression model did not corroborate to this finding.</p><p><strong>Conclusion: </strong>Duration of postmenopausal years had a significant association with menopause-specific quality of life of women.</p>","PeriodicalId":87478,"journal":{"name":"Menopause international","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2012-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1258/mi.2012.011107","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30738286","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 33
Women's health concern: the patient arm of the British Menopause Society. 妇女的健康问题:英国更年期协会的病人部门。
Pub Date : 2012-09-01 DOI: 10.1258/mi.2012.012033
John Stevenson
{"title":"Women's health concern: the patient arm of the British Menopause Society.","authors":"John Stevenson","doi":"10.1258/mi.2012.012033","DOIUrl":"https://doi.org/10.1258/mi.2012.012033","url":null,"abstract":"","PeriodicalId":87478,"journal":{"name":"Menopause international","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2012-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1258/mi.2012.012033","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30843100","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ten years on and where are we now? 十年过去了,我们现在在哪里?
Pub Date : 2012-09-01 DOI: 10.1258/mi.2012.012031
Edward Morris, Heather Currie
Having been involved for many years in advising, educating and always still learning about the menopause, the effects of estrogen deficiency and treatments, many changes have been seen but none so dramatic as the views on hormone replacement therapy (HRT). In the early days, HRT was seen as the answer to many problems and while it was known that it was not perfect and that all medicines carry some risk, it was strongly believed that for most women, the benefits outweighed the risks. Then, in July 2002, publication of the initial results of the Women’s Health Initiative (WHI) trial led us to be more concerned about risks and less aware of benefits with a subsequent huge fall in the use of HRT. Ten years on and a full review of the WHI trial and of other available evidence has been published. The key message appears to be that in fact, when used appropriately especially for women under the age of 60, or within 10 years of the menopause, HRT provides far more benefits than risks. It is re-assuring that the media have given this news some attention, since women and their health-care providers need to be aware of this information, so that they can make informed choices about the management of their menopause. It seems that for the last 10 years, decisions have been made based on incorrect information. Women can once again be re-assured that HRT is safe when used correctly and while not all women will need HRT, those who do need not worry unduly about risks but can enjoy the benefits. What is of great concern is that with reduced use of HRT over the last 10 years, some health-care professionals have become less familiar with the prescribing of HRT. Reports are being heard of more women being prescribed unopposed estrogen incorrectly, with four such cases being seen in 2011 in the editor’s region alone. Such cases were rare in the past. When investigated, all had endometrial hyperplasia which responded to progestogen therapy. Further discussions with primary care colleagues overwhelmingly revealed a lack of familiarity with types of HRT, e.g. with prescription of an estrogen only product which has a very similar name to a combined product, and examples of removal of Mirena and lack of appreciation that if HRT is continued, then progestogen must be added. Since it is likely that the use of HRT will increase, all those prescribing HRT should ensure that they are up to date with current thinking, principles and types. Many have stated that as a result of the WHI trial and the ensuing publicity, we have had 10 wasted years and that women have suffered unnecessarily. This may be the case but we cannot turn back the years and decisions were made in good faith. Lessons have been learnt and perhaps we should realize that major shifts in practice should not be based on one study, no matter how large. Further, over the last 10 years, aspects of menopause care have broadened away from HRT, leading to a better understanding of the consequences of estrogen deficienc
{"title":"Ten years on and where are we now?","authors":"Edward Morris,&nbsp;Heather Currie","doi":"10.1258/mi.2012.012031","DOIUrl":"https://doi.org/10.1258/mi.2012.012031","url":null,"abstract":"Having been involved for many years in advising, educating and always still learning about the menopause, the effects of estrogen deficiency and treatments, many changes have been seen but none so dramatic as the views on hormone replacement therapy (HRT). In the early days, HRT was seen as the answer to many problems and while it was known that it was not perfect and that all medicines carry some risk, it was strongly believed that for most women, the benefits outweighed the risks. Then, in July 2002, publication of the initial results of the Women’s Health Initiative (WHI) trial led us to be more concerned about risks and less aware of benefits with a subsequent huge fall in the use of HRT. Ten years on and a full review of the WHI trial and of other available evidence has been published. The key message appears to be that in fact, when used appropriately especially for women under the age of 60, or within 10 years of the menopause, HRT provides far more benefits than risks. It is re-assuring that the media have given this news some attention, since women and their health-care providers need to be aware of this information, so that they can make informed choices about the management of their menopause. It seems that for the last 10 years, decisions have been made based on incorrect information. Women can once again be re-assured that HRT is safe when used correctly and while not all women will need HRT, those who do need not worry unduly about risks but can enjoy the benefits. What is of great concern is that with reduced use of HRT over the last 10 years, some health-care professionals have become less familiar with the prescribing of HRT. Reports are being heard of more women being prescribed unopposed estrogen incorrectly, with four such cases being seen in 2011 in the editor’s region alone. Such cases were rare in the past. When investigated, all had endometrial hyperplasia which responded to progestogen therapy. Further discussions with primary care colleagues overwhelmingly revealed a lack of familiarity with types of HRT, e.g. with prescription of an estrogen only product which has a very similar name to a combined product, and examples of removal of Mirena and lack of appreciation that if HRT is continued, then progestogen must be added. Since it is likely that the use of HRT will increase, all those prescribing HRT should ensure that they are up to date with current thinking, principles and types. Many have stated that as a result of the WHI trial and the ensuing publicity, we have had 10 wasted years and that women have suffered unnecessarily. This may be the case but we cannot turn back the years and decisions were made in good faith. Lessons have been learnt and perhaps we should realize that major shifts in practice should not be based on one study, no matter how large. Further, over the last 10 years, aspects of menopause care have broadened away from HRT, leading to a better understanding of the consequences of estrogen deficienc","PeriodicalId":87478,"journal":{"name":"Menopause international","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2012-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1258/mi.2012.012031","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30843099","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Searching for pelvic floor muscle exercises on YouTube: what individuals may find and where this might fit with health service programmes to promote continence. 在YouTube上搜索骨盆底肌肉锻炼:个人可能会发现什么,以及这可能与促进自制的健康服务项目有什么关系。
Pub Date : 2012-09-01 Epub Date: 2012-07-03 DOI: 10.1258/mi.2012.012007
Kate Stephen, Grant P Cumming

Objective: This paper describes the investigation, categorization/characterization and viewing of pelvic floor muscle exercises (PFME) on YouTube from the perspective of the 'wisdom of the crowd'. The aim of the research was to increase awareness of the type of clips that individuals are likely to come across when searching YouTube and to describe trends and popularity. This awareness will be useful for the design of continence promotion services, especially for hard-to-reach individuals.

Study design: Web-based videos relating to PFE were identified by searching YouTube using the snowball technique. Main outcome measures Number of views; the approach taken (health, fitness, sexual and pregnancy); product promotion; and the use of music, visual cues and elements designed to encourage exercise. The number of views of each video was recorded at three points over a seven-month period.

Results: Twenty-two videos were identified. Overall these videos had been viewed over 430,000 times during the study period. One video was viewed over 100,000 times and overall the median increase in views was 59.4%.

Conclusions: YouTube is increasingly used to access information about pelvic floor exercises. Different approaches are used to communicate PFME information but there are no formal structures for quality control. Further research is required to identify which elements of the video clips are effective in communicating information and in motivating exercise and to establish appropriate protocols. Kitemarking is recommended in order that women obtain correct advice.

目的:本文从“人群智慧”的角度对YouTube上盆底肌运动(PFME)的调查、分类/表征和观看进行了描述。这项研究的目的是提高人们对个人在搜索YouTube时可能遇到的视频类型的认识,并描述趋势和受欢迎程度。这种认识将有助于设计促进自制的服务,特别是对难以接触到的个人。研究设计:通过使用滚雪球技术搜索YouTube来识别与PFE相关的网络视频。主要衡量指标:意见数;所采取的措施(保健、健身、性和怀孕);产品推广;使用音乐、视觉线索和旨在鼓励锻炼的元素。每个视频的观看次数是在七个月的时间里在三个点记录的。结果:鉴定出22个视频。总的来说,这些视频在研究期间被观看了超过43万次。其中一个视频的浏览量超过了10万次,总体浏览量中位数增长了59.4%。结论:YouTube越来越多地被用于获取骨盆底锻炼的信息。不同的方法用于交流PFME信息,但没有质量控制的正式结构。需要进一步研究,以确定录像片段的哪些部分在传播信息和鼓励锻炼方面是有效的,并制定适当的规程。建议做风筝标记,以便妇女获得正确的建议。
{"title":"Searching for pelvic floor muscle exercises on YouTube: what individuals may find and where this might fit with health service programmes to promote continence.","authors":"Kate Stephen,&nbsp;Grant P Cumming","doi":"10.1258/mi.2012.012007","DOIUrl":"https://doi.org/10.1258/mi.2012.012007","url":null,"abstract":"<p><strong>Objective: </strong>This paper describes the investigation, categorization/characterization and viewing of pelvic floor muscle exercises (PFME) on YouTube from the perspective of the 'wisdom of the crowd'. The aim of the research was to increase awareness of the type of clips that individuals are likely to come across when searching YouTube and to describe trends and popularity. This awareness will be useful for the design of continence promotion services, especially for hard-to-reach individuals.</p><p><strong>Study design: </strong>Web-based videos relating to PFE were identified by searching YouTube using the snowball technique. Main outcome measures Number of views; the approach taken (health, fitness, sexual and pregnancy); product promotion; and the use of music, visual cues and elements designed to encourage exercise. The number of views of each video was recorded at three points over a seven-month period.</p><p><strong>Results: </strong>Twenty-two videos were identified. Overall these videos had been viewed over 430,000 times during the study period. One video was viewed over 100,000 times and overall the median increase in views was 59.4%.</p><p><strong>Conclusions: </strong>YouTube is increasingly used to access information about pelvic floor exercises. Different approaches are used to communicate PFME information but there are no formal structures for quality control. Further research is required to identify which elements of the video clips are effective in communicating information and in motivating exercise and to establish appropriate protocols. Kitemarking is recommended in order that women obtain correct advice.</p>","PeriodicalId":87478,"journal":{"name":"Menopause international","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2012-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1258/mi.2012.012007","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30738285","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 19
Classification of premenstrual disorders as proposed by the International Society for Premenstrual Disorders. 国际经前紊乱学会提出的经前紊乱分类。
Pub Date : 2012-06-01 DOI: 10.1258/mi.2012.012017
Suman Kadian, Shaughn O'Brien

Premenstrual disorders have been recognized as affecting innumerable women for decades but unlike most other medical conditions universally accepted criteria for definition and diagnosis are not established. Although premenstrual syndrome (PMS) occurs throughout reproductive life, there are some women who become particularly troubled. Those approaching the menopause may also have a mixture of PMS and menopause symptoms, not to mention heavy periods. Furthermore, some of the symptoms are similar in nature and so it is a challenge to identify which set of symptoms belongs to which spectrum. This is an area that has not been explored well. Various classifications have been proposed over the last few decades. A further effort towards the classification was made by an international multidisciplinary group of experts established as the International Society for Premenstrual Disorders (ISPMD) in Montreal in September 2008. Their deliberations resulted in a unified diagnosis, classification of premenstrual disorders (PMD) along with their quantification and guidelines on clinical trial design. This classification of PMS is far more comprehensive and inclusive than previous attempts. PMD in the ISPMD Montreal consensus are divided into two categories: Core and Variant PMD. Core PMD are typical, pure or reference disorders associated with spontaneous ovulatory menstrual cycles while Variant PMD exist where more complex features are present. Further, the consensus group considered that PMD may be subdivided into three subgroups predominantly physical, predominantly psychological and mixed. Variant PMD encompass primarily four different types; premenstrual exacerbation, PMD with anovulatory ovarian activity, PMD with absent menstruation and progestogen-induced PMD.

经前紊乱几十年来一直被认为影响着无数妇女,但与大多数其他医疗状况不同,尚未建立普遍接受的定义和诊断标准。虽然经前综合症(PMS)发生在整个生育期,但有些女性会变得特别困扰。那些接近更年期的人也可能同时有经前综合症和更年期症状,更不用说月经过多了。此外,有些症状在性质上是相似的,因此确定哪一组症状属于哪一种谱系是一项挑战。这是一个尚未被充分开发的领域。在过去的几十年里,人们提出了各种各样的分类。2008年9月在蒙特利尔成立的国际经前紊乱学会(ISPMD)国际多学科专家组为分类作出了进一步努力。他们的审议导致了统一的诊断,经前期疾病(PMD)的分类,以及他们的量化和临床试验设计指南。这种经前症候群的分类比以前的尝试更加全面和包容。ISPMD蒙特利尔共识中的PMD分为两类:核心PMD和变体PMD。核心经前症候群是典型的、纯粹的或与月经周期自发排卵相关的疾病,而变异型经前症候群则存在更复杂的特征。此外,共识组认为PMD可以细分为三个亚组,主要是生理的,主要是心理的和混合的。变体PMD主要包括四种不同的类型;经前加重,经前综合症伴无排卵性卵巢活动,经前综合症伴月经不调和孕激素诱导的经前综合症。
{"title":"Classification of premenstrual disorders as proposed by the International Society for Premenstrual Disorders.","authors":"Suman Kadian,&nbsp;Shaughn O'Brien","doi":"10.1258/mi.2012.012017","DOIUrl":"https://doi.org/10.1258/mi.2012.012017","url":null,"abstract":"<p><p>Premenstrual disorders have been recognized as affecting innumerable women for decades but unlike most other medical conditions universally accepted criteria for definition and diagnosis are not established. Although premenstrual syndrome (PMS) occurs throughout reproductive life, there are some women who become particularly troubled. Those approaching the menopause may also have a mixture of PMS and menopause symptoms, not to mention heavy periods. Furthermore, some of the symptoms are similar in nature and so it is a challenge to identify which set of symptoms belongs to which spectrum. This is an area that has not been explored well. Various classifications have been proposed over the last few decades. A further effort towards the classification was made by an international multidisciplinary group of experts established as the International Society for Premenstrual Disorders (ISPMD) in Montreal in September 2008. Their deliberations resulted in a unified diagnosis, classification of premenstrual disorders (PMD) along with their quantification and guidelines on clinical trial design. This classification of PMS is far more comprehensive and inclusive than previous attempts. PMD in the ISPMD Montreal consensus are divided into two categories: Core and Variant PMD. Core PMD are typical, pure or reference disorders associated with spontaneous ovulatory menstrual cycles while Variant PMD exist where more complex features are present. Further, the consensus group considered that PMD may be subdivided into three subgroups predominantly physical, predominantly psychological and mixed. Variant PMD encompass primarily four different types; premenstrual exacerbation, PMD with anovulatory ovarian activity, PMD with absent menstruation and progestogen-induced PMD.</p>","PeriodicalId":87478,"journal":{"name":"Menopause international","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2012-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1258/mi.2012.012017","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30630985","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 41
期刊
Menopause international
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1